30 March 2020

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

30 March 2020 | n=27

  1. Tang EC, Vittinghoff E, Philip SS, Doblecki-Lewis S, et al.
    Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV pre-exposure prophylaxis.
    AIDS 2020.

  2. Panpradist N, Beck IA, Ruth PS, Avila-Rios S, et al.
    Near point-of-care, point-mutation test to detect drug resistance in HIV-1: a validation study in a Mexican cohort.
    AIDS 2020.

  3. Armstrong WS.
    The HIV Workforce in Crisis: An Urgent Need to Build the Foundation Required to End the Epidemic.
    Clin Infect Dis 2020.

  4. Budak JZ, Sears DA, Wood BR, Spach DH, et al.
    HIV Training Pathways in Residency: A National Survey of Curricula and Outcomes.
    Clin Infect Dis 2020.

  5. Garvey LJ, Cooke GS, Smith C, Stingone C, et al.
    Decline in Hepatitis C Virus (HCV) Incidence in Men Who Have Sex With Men Living With Human Immunodeficiency Virus: Progress to HCV Microelimination in the United Kingdom?
    Clin Infect Dis 2020.

  6. Ramirez JA, Maddali MV, Nematollahi S, Li JZ, et al.
    New Strategies in Clinical Guideline Delivery: Randomized trial of online, interactive decision-support versus guidelines for HIV treatment selection by trainees.
    Clin Infect Dis 2020.

  7. Bono RS, Dahman B, Sabik LM, Yerkes LE, et al.
    HIV-Experienced Clinician Workforce Capacity: Urban-Rural Disparities in the US South.
    Clin Infect Dis 2020.

  8. Yin S, Barker L, Ly KN, Kilmer G, et al.
    Susceptibility to Hepatitis A Virus Infection in the United States, 2007-2016.
    Clin Infect Dis 2020.

  9. Slomski A.
    Leading HIV Vaccine Trial Stopped for Ineffectiveness.
    JAMA 2020;323:1124.

  10. Cattaneo D, Riva A, Columpsi P, Lapadula G, et al.
    Dosing of dolutegravir in TB/HIV co-infected patients on rifampicin: twice is (always) better than once.
    J Acquir Immune Defic Syndr 2020.

  11. Kamitani E, Johnson WD, Wichser ME, Adegbite AH, et al.
    Growth in proportion and disparities of HIV PrEP use among key populations identified in the United States national goals: systematic review & meta-analysis of published surveys.
    J Acquir Immune Defic Syndr 2020.

  12. Lallemant M, Amzal B, Sripan P, Urien S, et al.
    Perinatal antiretroviral intensification to prevent intrapartum HIV transmission when antenatal antiretroviral therapy is initiated less than 8 weeks prior to delivery.
    J Acquir Immune Defic Syndr 2020.

  13. Das S, Allston A, Kharfen M.
    Detecting spatial cores and temporal trends of repeat STIs to plan Pre-Exposure Prophylaxis (PrEP) scale-up in DC.
    J Acquir Immune Defic Syndr 2020.

  14. Ramirez-Marrero FA, Perez-Frontera S, Amalbert-Birriel MA, Matos M, et al.
    Effects of low volume high intensity interval training in Hispanic HIV+ Women: a non-randomized study.
    J Acquir Immune Defic Syndr 2020.

  15. Hensen B, Schaap AJ, Mulubwa C, Floyd S, et al.
    Who accepts and who uses community-based secondary distribution HIV self-testing (HIVST) kits? Findings from the intervention arm of a cluster-randomised trial of HIVST distribution nested in four HPTN 071 (PopART) communities in Zambia.
    J Acquir Immune Defic Syndr 2020.

  16. Kostev K.
    Sex Differences in People Aging with HIV in Germany.
    J Acquir Immune Defic Syndr 2020.

  17. Oyaro P, Kwena Z, Bukusi EA, Baeten JM, et al.
    Is HIV self-testing a strategy to increase repeat testing among pregnant and postpartum women? A pilot mixed methods study.
    J Acquir Immune Defic Syndr 2020.

  18. Paolillo EW, Pasipanodya EC, Moore RC, Pence BW, et al.
    Cumulative Burden of Depression and Neurocognitive Decline among Persons with HIV: A Longitudinal Study.
    J Acquir Immune Defic Syndr 2020.

  19. Davey S, Ajibola G, Maswabi K, Sakoi M, et al.
    Mother-to-Child HIV Transmission with in utero Dolutegravir vs. Efavirenz in Botswana.
    J Acquir Immune Defic Syndr 2020.

  20. Alli BY, Burk RD, Fatahzadeh M, Grossberg RM, et al.
    HIV modifies the effect of tobacco smoking on oral human papillomavirus infection.
    J Infect Dis 2020.

  21. Balagopal A, Smeaton LM, Quinn J, Venuto CS, et al.
    Intrahepatic Viral Kinetics during Direct-Acting Antivirals for Hepatitis C in HIV Co-infection:The ACTG A5335S Substudy.
    J Infect Dis 2020.

  22. Martinez L, Cords O, Horsburgh CR, Andrews JR, et al.
    The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis.
    Lancet 2020;395:973-984.

  23. Lane R.
    Sean Wasserman: rising star in TB-HIV research and medicine.
    Lancet 2020;395:941.

  24. Barras C.
    Transplant success reignites interest in reprogramming cells against HIV.
    Nat Med 2019.

  25. Kozal M, Aberg J, Pialoux G, Cahn P, et al.
    Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection.
    N Engl J Med 2020;382:1232-1243.

  26. Grandi V, De Francesco I.
    Penile Kaposi's Sarcoma.
    N Engl J Med 2020;382:e20.

  27. Currier JS.
    Monthly Injectable Antiretroviral Therapy - Version 1.0 of a New Treatment Approach.
    N Engl J Med 2020;382:1164-1165.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

30 March 2020

23 March 2020

16 March 2020

09 March 2020

02 March 2020

30 March 2020

Multidisciplinary Journal Club

  1. Sen A, Jette N, Husain M, Sander JW, et al.
    Epilepsy in older people.
    Lancet. 2020;395:735-748.

  2. Simon TG, Duberg AS, Aleman S, Chung RT, et al.
    Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality.
    N Engl J Med. 2020;382:1018-1028.

  3. van der Pluijm RW, Tripura R, Hoglund RM, Pyae Phyo A, et al.
    Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
    Lancet. 2020 Mar 11. pii: S0140-6736(20)30552.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016